[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UY27122A1 - A PHARMACEUTICAL COMPOSITION THAT INCLUDES 2 TO 4 MG OF 5- (A- (2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI) BENCIL) TIAZOLIDIN-2,4-DIONA - Google Patents

A PHARMACEUTICAL COMPOSITION THAT INCLUDES 2 TO 4 MG OF 5- (A- (2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI) BENCIL) TIAZOLIDIN-2,4-DIONA

Info

Publication number
UY27122A1
UY27122A1 UY27122A UY27122A UY27122A1 UY 27122 A1 UY27122 A1 UY 27122A1 UY 27122 A UY27122 A UY 27122A UY 27122 A UY27122 A UY 27122A UY 27122 A1 UY27122 A1 UY 27122A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutical composition
tiazolidin
piridil
etoxi
bencil
Prior art date
Application number
UY27122A
Other languages
Spanish (es)
Inventor
Jai Patel
Hamisn Ross
Robin Price
Jeffrey Roger Granett
Original Assignee
Smithkline Beecham P L C Y Smi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P L C Y Smi filed Critical Smithkline Beecham P L C Y Smi
Priority to UY27122A priority Critical patent/UY27122A1/en
Publication of UY27122A1 publication Critical patent/UY27122A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención describe una composición farmacéutica que comprende Compuesto (I), caracterizada porque la composición comprende de 2 a 12 mg de Compuesto (I) en una forma farmacéuticamente aceptable y opcionalmente un vehículo farmacéuticamente aceptable para el mismo, la utilización de tal composición en medicina.The present invention describes a pharmaceutical composition comprising Compound (I), characterized in that the composition comprises from 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier thereof, the use of such composition in medicine.

UY27122A 2002-01-11 2002-01-11 A PHARMACEUTICAL COMPOSITION THAT INCLUDES 2 TO 4 MG OF 5- (A- (2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI) BENCIL) TIAZOLIDIN-2,4-DIONA UY27122A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27122A UY27122A1 (en) 2002-01-11 2002-01-11 A PHARMACEUTICAL COMPOSITION THAT INCLUDES 2 TO 4 MG OF 5- (A- (2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI) BENCIL) TIAZOLIDIN-2,4-DIONA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27122A UY27122A1 (en) 2002-01-11 2002-01-11 A PHARMACEUTICAL COMPOSITION THAT INCLUDES 2 TO 4 MG OF 5- (A- (2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI) BENCIL) TIAZOLIDIN-2,4-DIONA

Publications (1)

Publication Number Publication Date
UY27122A1 true UY27122A1 (en) 2002-07-31

Family

ID=38812565

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27122A UY27122A1 (en) 2002-01-11 2002-01-11 A PHARMACEUTICAL COMPOSITION THAT INCLUDES 2 TO 4 MG OF 5- (A- (2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI) BENCIL) TIAZOLIDIN-2,4-DIONA

Country Status (1)

Country Link
UY (1) UY27122A1 (en)

Similar Documents

Publication Publication Date Title
RS52169B (en) Stable laquinimod preparations
GEP20074047B (en) Pramipexole once-daily dosage form
AR038527A1 (en) DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS ACTIVE INGREDIENT
RS51569B (en) Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol
CO5600999A2 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE INHIBITORS OF VALSARTAN AND NEUTRAL ENDOPEPTIDASE
ECSP055568A (en) COMPOSITION OF PRAMIPEXOL SUSTAINED RELEASE COMPRESSED
MX2009004203A (en) Acetaminophen / ibuprofen combinations.
HK1098372A1 (en) Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein
HK1089950A1 (en) Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
CO5280073A1 (en) COMPOSITIONS
PT1727551E (en) Pharmaceutical composition comprising a benzodiazepine derivative and a inhibitor of the rsv fusion protein
DE602008006243D1 (en) PHARMACEUTICAL COMBINATION OF ALISKIRES AND VALSARTAN
CO5640087A2 (en) COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY PHARMACOS DECONGESTIONANTES AND ANTI-HISTAMINIC
BRPI0415053A (en) p-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
BRPI0412364A (en) solid pharmaceutical composition comprising amisulpride
AR039162A1 (en) VENLAFAXINA FORMULATIONS OF EXTENDED LIBERATION
UY27122A1 (en) A PHARMACEUTICAL COMPOSITION THAT INCLUDES 2 TO 4 MG OF 5- (A- (2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI) BENCIL) TIAZOLIDIN-2,4-DIONA
AR045724A1 (en) ORODISPERSABLE PHARMACEUTICAL COMPOSITION OF AN ANTITROMBOTIC COMPOUND
AR043016A2 (en) AN ELTIRIPTAN ANTIMIGRANIC COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING IT
UY26176A1 (en) POLYMORPHIC FORMS OF A AZOBICICLO CITRATE (2,2,2) OCTAN-3-AMINE AND ITS PHARMACEUTICAL COMPOSITIONS.
UY27771A1 (en) PROCEDURE TO PREPARE PHARMACEUTICAL COMPOSITIONS OF 2 TO 8 MG OF 5- (4- (2- (N-METHYL.N (2-PIRIDYL) AMINO) ETOXI) BENCILO) TIAZOLIDINO-2,4-DIONA.
AR040764A1 (en) PHARMACEUTICAL FORMULATIONS OF EPINASTINE, PSEUDOEFEDRINE AND METHYLFEDRINE
ATE357220T1 (en) MODIFIED RELEASE PHARMACEUTICAL COMPOSITION
ECSP045295A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE 2- (4-ETOXI-PHENYL) -3- (4-METHANOSULPHONYL-PHENYL) -PIRAZOLO'1,5-BIPIRIDACINA IN NANOPARTICULATED FORM
AR030660A1 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AN ILLNESS ASSOCIATED WITH AN EXCESS OF IL-12 PRODUCTION

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160623